SCHEMBL4698390

SCHEMBL4698390

c1ccc(-c2nnn(-c3cncc(Nc4cccnc4)c3)n2)nc1

nearest known ligand 0.77

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 16/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4701515 0.91 GRM5 (0.77) GRM5
SCHEMBL4703402 0.88 GRM5 (0.73) GRM5
SCHEMBL4699464 0.87 GRM5 (1.00) GRM5
SCHEMBL4703654 0.83 GRM5 (0.66) GRM5
SCHEMBL4698877 0.83 GRM5 (0.74) GRM5
SCHEMBL13683884 0.82 GRM5 (0.82) GRM5
SCHEMBL4701728 0.81 GRM5 (0.83) GRM5
SCHEMBL6165528 0.80 GRM5 (0.84) GRM5
SCHEMBL4698862 0.80 GRM5 (0.70) GRM5
SCHEMBL4700974 0.78 GRM5 (0.58) GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1434773-B1 HETEROARYL SUBSTITUTED TETRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO INC (US) 2008-05-21 EP claimed
WO-2004030637-A2 TREATMENT OF OBESITY AND OTHER DISORDERS ASSOCIATED WITH EXCESSIVE FOOD INTAKE MERCK & CO., INC. (US) 2004-04-15 WO claimed
US-7253190-B2 Heteroaryl substituted tetrazole modulators of metabotrophic glutamate receptor-5 MERCK & CO., INC. (US) 2007-08-07 US disclosed